Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, is pleased to announce the appointment of Greg DiPasquale as Senior Vice President, Head of Commercial, effective immediately.
- Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, is pleased to announce the appointment of Greg DiPasquale as Senior Vice President, Head of Commercial, effective immediately.
- DiPasquale will oversee sales, marketing, and sales operations for Harrow’s rapidly growing portfolio of branded ophthalmic products.
- John Saharek, Harrow’s Chief Commercial Officer and Chief Executive Officer of ImprimisRx, will continue to oversee Harrow’s commercial business, focusing on the day-to-day management of Harrow’s market‑leading compounded division.
- DiPasquale’s extensive experience also includes executive leadership positions at Bausch + Lomb as Vice President of Sales for the U.S.